vancomycin has been researched along with cefoperazone in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (12.50) | 18.7374 |
| 1990's | 5 (31.25) | 18.2507 |
| 2000's | 2 (12.50) | 29.6817 |
| 2010's | 4 (25.00) | 24.3611 |
| 2020's | 3 (18.75) | 2.80 |
| Authors | Studies |
|---|---|
| Kwon, DH; Lu, CD | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| He, T; Hu, Y; Li, H; Pu, Q; Wu, W; Xia, X; Zhang, J; Zhang, Q | 1 |
| Bai, H; Chen, W; Fu, G; He, T; Hu, Y; Li, L; Luo, G; Qu, R; Tang, X; Wang, W; Xia, X; Xu, L; Zhang, J; Zhao, X | 1 |
| Isert, D; Klesel, N; Limbert, M; Markus, A; Schrinner, E; Seibert, G | 1 |
| Fasching, CE; Gerding, DN; Moody, JA; Peterson, LR; Sinn, LM | 1 |
| Fleming, PC; Karmali, MA; Lane, J; Roscoe, M; Simor, AE; Smith, SS | 1 |
| Calderwood, SB; Jackson, E; Tung, CC | 1 |
| Hayashi, I; Ichiki, M; Ishikawa, T; Karato, A; Niida, M; Ogawa, M; Sakurai, M; Sekine, I; Shiotani, J; Yoshida, T | 1 |
| Nakagawa, Y; Toyoguchi, T | 1 |
| Abi-Said, D; Bodey, G; Raad, I; Rolston, K; Whimbey, E | 1 |
| Aleksandrova, IV; Borisova, LA; Chernen'kaia, TV; Kosolapov, DA; Nikitina, OV; Reĭ, SI | 1 |
| Chen, H; Li, S; Niu, DK; Wang, H; Wang, Q; Yin, Y | 1 |
| Fang, X; Xuan, J; Yang, Y; Yao, J; Zhang, Q | 1 |
1 review(s) available for vancomycin and cefoperazone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for vancomycin and cefoperazone
| Article | Year |
|---|---|
[Laboratory and clinical studies on combined effects of fosfomycin plus sulbactam/cefoperazone for mixed infections of MRSA and Pseudomonas aeruginosa].
Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cefoperazone; Dibekacin; Drug Therapy, Combination; Female; Fosfomycin; Humans; Male; Methicillin Resistance; Middle Aged; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Sulbactam; Vancomycin | 1994 |
Imipenem or cefoperazone-sulbactam combined with vancomycin for therapy of presumed or proven infection in neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cefoperazone; Drug Therapy, Combination; Humans; Imipenem; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Sulbactam; Vancomycin | 1996 |
13 other study(ies) available for vancomycin and cefoperazone
| Article | Year |
|---|---|
Polyamine effects on antibiotic susceptibility in bacteria.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Drug Resistance, Bacterial; Drug Synergism; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Polyamines; Spermine; Staphylococcus aureus | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Novel Stapling by Lysine Tethering Provides Stable and Low Hemolytic Cationic Antimicrobial Peptides.
Topics: Amino Acid Sequence; Antimicrobial Cationic Peptides; Escherichia coli; HEK293 Cells; Hemolysis; Humans; Lysine; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests | 2020 |
Lysine-Tethered Stable Bicyclic Cationic Antimicrobial Peptide Combats Bacterial Infection in Vivo.
Topics: Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Antimicrobial Peptides; Bacterial Infections; Humans; Lysine; Microbial Sensitivity Tests | 2022 |
The in-vitro antibacterial activity of a combination of cefpirome or cefoperazone with vancomycin against enterococci and Staphylococcus aureus.
Topics: Cefoperazone; Cefpirome; Cephalosporins; Drug Therapy, Combination; Enterococcus; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus; Vancomycin | 1992 |
Treatment evaluation of experimental staphylococcal infections: comparison of beta-lactam, lipopeptide, and glycopeptide antimicrobial therapy.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cefamandole; Cefoperazone; Cephalothin; Daptomycin; Disease Models, Animal; Female; Glycopeptides; Oxacillin; Peptides; Rabbits; Staphylococcal Infections; Sulbactam; Teicoplanin; Vancomycin | 1990 |
Evaluation of a blood-free, charcoal-based, selective medium for the isolation of Campylobacter organisms from feces.
Topics: Agar; Blood; Campylobacter; Campylobacter fetus; Cefoperazone; Charcoal; Culture Media; Cycloheximide; Enterobacteriaceae; Feces; Hemin; Pyruvates; Vancomycin | 1986 |
Measurement of levels of aminoglycosides and vancomycin in serum in the presence of new beta-lactam antibiotics.
Topics: Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Cefoperazone; Cefotaxime; Humans; Immunoenzyme Techniques; Mezlocillin; Moxalactam; Penicillins; Piperacillin; Vancomycin | 1984 |
[Nephrotoxicity and drug interaction of vancomycin (2)].
Topics: Animals; Blood Urea Nitrogen; Cefoperazone; Ceftazidime; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Creatinine; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Fosfomycin; Imipenem; Kidney; Male; Organ Size; Rabbits; Vancomycin | 1996 |
[Pattern dynamics of bacteriemia and sepsis pathogens in ICU patients of emergency service].
Topics: Acetamides; Acinetobacter; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Candida; Candidiasis; Carbapenems; Cefoperazone; Drug Resistance, Multiple, Bacterial; Enterococcus; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Klebsiella pneumoniae; Linezolid; Methicillin; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Sepsis; Sulbactam; Vancomycin | 2013 |
Genotypic variations between wild-type and small colony variant of Staphylococcus aureus in prosthetic valve infectious endocarditis: a comparative genomic and transcriptomic analysis.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; Cefoperazone; Endocarditis; Female; Gene Expression Profiling; Genome, Bacterial; Genotype; Heart Valve Prosthesis; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Polymorphism, Single Nucleotide; Staphylococcal Infections; Sulbactam; Transcriptome; Vancomycin; Virulence | 2018 |
Successful treatment of a patient with multi-site infection of cerebrospinal fluid and testis due to Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Cefoperazone; Cerebrospinal Fluid; Drug Combinations; Epididymis; Humans; Klebsiella Infections; Klebsiella pneumoniae; Magnetic Resonance Imaging; Male; Meropenem; Middle Aged; Perineum; Skull; Sulbactam; Testis; Ultrasonography; Vancomycin | 2021 |